semaglutide alcohol use disorder Semaglutide Shows Promise in Curbing Alcohol Cravings

First RCT of semaglutide in patients with alcohol use disorder and obesity (n=88 completers, Novo Nordisk-funded): #semaglutide cut heavy drinking days and improved multiple alcohol‑related and somatic outcomes. https://t.co/TJr9heD9dG

21.96

★★★★☆4.8 (126)

While only three medications have been FDA-approved for alcohol use disorder in the last 75 years, #semaglutide is emerging as a potent new candidate for helping patients cut back on drinking. John

22.21

★★★★★4.9 (98)

Low-dose semaglutide reduces alcohol consumption and cravings in early trial

29.91

★★★★★5.0 (157)

GLP-1 Alcohol Cravings: How Ozempic Helps Quit Drinking

24.53

★★★★★4.7 (84)

IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target

23.73

★★★★★4.9 (203)

🚨 🍻 Semaglutide isn’t just about weight—it may also help quiet alcohol cravings and cut down heavy drinking, opening the door to a new way of supporting people with alcohol use disorder., #semaglutide

26.59

★★★★★5.0 (176)

Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity

22.63

★★★★★4.8 (132)